Stephens Inc’s Medline Inc MDLN Stock Holding History

Stephens Inc’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.23M	Buy	132,663 +46,483	+54%	+$1.87M	0.06%	299
2026 Q1	$3.84M	Buy	+86,180	New	+$3.81M	0.05%	340

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Stephens Inc's MDLN Position: Q2 2026 in Review

Stephens Inc increased its Medline Inc (MDLN) stake by 54% in Q2 2026, buying an estimated $1.87M and bringing the position to 132,663 shares worth $5.23M. The position accounts for 0.06% of the portfolio, ranked #299.

Stephens Inc first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Stephens Inc held 132,663 shares of Medline Inc worth $5.23M as of Q2 2026.
Stephens Inc bought 46,483 Medline Inc shares in Q2 2026, an estimated $1.87M.
Medline Inc made up 0.06% of Stephens Inc's portfolio in Q2 2026, its #299 holding.
Stephens Inc first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.